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A b s t r a c t  
The present study evaluated the anti-depressant properties of A. calamus rhizome in a forced 
swimming test (FST) of mice model. Three doses of methanol extract of rhizome (200,400 and 600 mg 
extract/kg b.wt) and imipramine (15 mg/kg b.wt), a positive control, were orally administered once a 
day for the consecutive period of 14 days in Balb/c mice. The effect of extract on immobility period was 
measured using forced swimming test. The levels of cortisol monoamine oxidase and 
neurotransmitters were analyzed using standard methods. The anti-depressant effect was observed 
maximum at the dose of 200 mg/kg. b.wt that caused 23.82% reduction in immobility period. The 
extract also significantly attenuated the FST-induced elevation of plasma cortisol, monoamine oxidase 
activity and returned the altered levels of neurotransmitters near to the normal levels in brain. These 
results of the present study suggest that the extract of A. calamus rhizome  has  antidepressant-like 
activity which is mediated by modulating the central neurochemical as well as HPA (hypothalamic-
pituitary-adrenal) axis in response to stress induced by FST. Therefore, A.calamus rhizome may be 
used as a valuable herbal supplement for the treatment of depression related conditions. 
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Introduction 
Depression is a common mental disorder, characterized by 
sadness, loss of interest or pleasure, feelings of guilt or low self-
worth, disturbed sleep or appetite, poor concentration etc [1].  
These problems can become chronic or recurrent, substantially 
impairing an individual’s ability to cope with daily life. Depressive 
illness affects nearly 10-20% of the population worldwide [2]. The 
dysfunctions of the serotonergic and neuroendocrinological 
systems in response to chronic stresses are one of the triggers that 
provoke the depressive illness [3]. Clinical studies have shown that 
the hyperactivity of the HPA axis (hypothalamic-pituitary-adrenal) 
chronically elevates the cortisol level by stimulating the 
hypersecretion of corticotrophin-releasing factor (CRF). Moreover, 
the impaired neurotransmission decreases the level of 
neurotransmitters in the brain, contributing to the development of 
depression in susceptible individuals. 
Pharmaceutical antidepressants are generally the first line of 
treatment for depression that exerts their effect by increasing the 
levels of monoamine (5-hydroxytryptamine (5-HT), norepinephrine 
(NE), and dopamine (DA). Due to the slow-onset, low response 
and several side effects of currently available drugs, newer natural 
substances from the medicinal and herbal sources are often sought 
by people as a complementary and alternative remedy to their 
pharmaceutical medications. The advantages of using herbal 
medicines are numerous, in particular that they are more effective 
for long-standing health complaints that do not respond well to 
traditional medicine. Plants such as Ginko biloba, Psoralia 
corylifolia, Hypericum reflexum, Curcuma longa, Allium 
macrostemon, Asparagus racemosus have been proved to have 
potential antidepressant-like properties[4-6]. Further, many new 
plant sources are also being screened and evaluated for better 
management of depression throughout the world.  
Acorus. calamus (Calamus or Sweet flag), an ethnomedicinally 
important herbal plant, belongs to the family Acoracea[7]. Various 
studies have shown that the rhizome and leaves of this plant 
posses a range of pharmacological effects such as 
hepatoproective[8], hypolipidemic[9], anti-inflammatory[10-11], 
radio-protective[21], anti-adipogenic activity[13], anti-diabetic[14] 
etc. There are also reports indicating the use of this plant in 
treating CNS abnormalities[15-16]. GC-MS analysis has shown 
that the volatile oil extracted from this plant contains β-asarone as 
the main active constituent among others[17]. The rhizome also 
contains other phytochemicals such as polyphenols, flavonoids, 
saponins, etc. Our earlier report demonstrated the protective effect 
of methanol extract of A.calamus rhizome against hepatotoxicity 
and oxidative stress in rats[18]. Here, we report for the protective 
effect of the rhizome extract with respect to its anti-depressive 
properties in mice. 
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Materials and methods 
Plant material  
The rhizomes of A. calamus were collected in the January month of 
year 2011 from a botanical garden in Mysore, India and the plant 
material was identified and authenticated by Dr.Sudharhan, 
botanist, Mysore University, Mysore. The plant material was shade 
dried and powdered to fine particles using a mixer. 200 g of 
powdered plant material was extracted with methanol using orbital 
shaker (1:10 ratio). Extract obtained was passed through Whatman 
filter paper No.1 and the methanol was flash evaporated and the 
extract stored at -20°C. 
Experimental design 
For the animal experiment, male Balb/c mice weighing about 20-25 
g were used. These mice had free access to laboratory feed and 
tap water under standard laboratory conditions. The animals used 
in the present study were maintained in accordance with the 
guidelines of National Institute of Nutrition, India and approved by 
Institutional Animal Ethics Committee (IAEC). Experiments, 
performed by an observer who was unaware of the each treatment, 
were carried out between 1-3 p.m. For the behavioral test, different 
doses of the extract and a standard drug (Imipramine) were given 
by gastric gavage once daily over a period of 14 days. Behavioral 
test was conducted 1 hour after the last treatment as described 
below. 
Forced swimming test (FST) 
The procedure was same as that described by Porsolt et al[19].  36 
mice were randomly divided into 6 groups and treated as follow: 
Group I served as normal control and group II received Tween-80 
suspensions. Group III-V were orally administered with various 
doses of A.calamus extract (200,400 and 600 mg extract/kg of 
body weight) and group VI received standard antidepressant drug-
imipramine (15 mg/kg bd.wt). All the groups of mice were subjected 
to swimming test except group I. In a cylindrical glass aquarium (20 
x 12 cm diameter), animals were allowed to swim for 6 min and the 
duration of immobility was recorded for the last 4 min using a video 
tracking system. The mouse was considered immobile whenever it 
stopped swimming and floating in the water, with its head just 
above the water level. Animals were sacrificed on the last day of 
the experiment and bled between 1-3 pm to avoid the variation on 
the hormonal levels due to circadian rhythms. Blood was collected 
and plasma was separated in a refrigerated centrifuge at 4°C. 
Determination of neurotransmitter levels 
Mouse brain monoamine neurotransmitters viz 5-HT, NA and DA 
levels were measured by HPLC coupled with electrochemical 
detection[20].The brain tissue were homogenized in 0.4 M 
perchloric acid containing 5 mM sodium bisuphite, 0.04 mM EDTA 
and then centrifuged at 15,000 rpm for 15 min at 4°C. 20 µl of the 
resulting supernatant was chromatographed on a C18 RP-18 
column (150 mm x 4.6 mm, 5 µm). The separation was done in an 
isocratic elution mode at column temperature of 25°C using a 
mobile phase consisting of 17.6% methanol, 82.4% water 
containing EDTA2Na (0.0876 mM), triethylamine (1.5 mM), DL-
camphorsulphonic acid (9 mM), disodium phosphate (20 mM) and 
citrate (9 mM) at a flow rate of 0.7 ml/min. The measurement was 
done at electropotentials of a glassy carbon electrode +650 mV 
versus Ag/AgCl reference electrode with Waters electrochemical 
detectors. Neurotransmitters were identified and quantified by 
comparing their retention times and peak areas with those of 
standard solutions. 
Measurement of MAO-A and MAO-B activities 
Mice brain mitochondrial fraction was prepared following the 
procedure of Schurr and Livne [21] . MAO activity was measured 
as per the method described by Yu et al., 2002[22]. Protein 
concentration was measured using kit from Agappe (Agappe 
Diagnostics Ltd, Kerala). The assay mixture contained 100 µl of 4 
mM 5-hydroxy tryptamine and 100 µl of 2 mM β-PEA as the 
specific substrate for MAO-A and MAO-B plus 200 µl of 
mitochondrial fraction and sodium phosphate buffer (100 mM, pH 
7.4) up to a final volume of 1 ml. The reaction was allowed to 
proceed for 20 min at 37°C and finally stopped by addition of 200 µl 
of 1M HCl. The reaction product was extracted with 4 ml of 
butylacetate and cyclohexane for MAO-A and B respectively. The 
upper organic phase was measured at 280 nm and 242 nm for 
MAO-A and MAO-B respectively using spectrophotometer. 
Measurement of Cortisol level 
The plasma cortisol level was estimated using EIA kit (Cayman 
chemical company, USA). 
Locomotory activity test 
For the measurement of locomotory activity naive mice were 
placed in an open field (60 x 30 x 30 cm) with black background. 
The apparatus was divided into equal areas by both parallel and 
perpendicular lines. In this experiment the animals received the 
same dose of extracts and standard as used for the forced 
swimming test. The experiment was recorded with a video camera 
and the motion activity (number of square crossed) was counted 
for 5 min. 
Statistical analysis 
Data are shown as mean ± standard deviation. Comparison 
between groups was analyzed by Tukey’s honestly significant 
difference (HSD) method. The p values less than 0.05 were 
considered as significantly different. 
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Results 
The effect of extract on the body weight change is presented in 
Table 1.  
 
Table 1. Effect of oral administration of methanolic extract of 
A.calamus rhizome on body weight gain of mice.  
Data shows that there is no difference in body weight gain among 
all the groups after 14 days of oral administration. Figure 1  
 
Figure 1.Effect of methanolic extract of A.calamus rhizome on 
immobility period of mice in FST. Group I (normal control), Group II 
(Stress control), Group III (AC, 100 mg/kg), Group IV (AC, 200 
mg/kg), Group V (AC, 400mg/kg), Group VI (Imipiramine) 
 
shows that the administration of extract significantly shortened the 
immobility time in FST at the dose of 200 and 400 mg/kg b.wt 
compared to stress control. The maximum antidepressant effect 
was obtained at 200 mg which resulted in 23.82% immobility 
reduction, while the 400 mg dose caused only 12.52% reduction. 
On the other hand, the extract at lower dose of 100 mg failed to 
alter the duration of immobility significantly. Overall, the effect was 
in an inverted U-shaped dose-dependant fashion. The standard 
antidepressant (imipiramine) produced a marked reduction in 
immobility time by 40.61%. 
Swim stress procedure evoked a significant 1.8 fold increase 
(Figure 2)  
 
 
Figure 2.Effect of methanolic extract of A.calamus rhizome on 
serum cortisol level mice in FST. Group I (normal control), Group II 
(Stress control), Group III (AC, 100 mg/kg), Group IV (AC, 200 
mg/kg), Group V (AC, 400 mg/kg), Group VI (Imipiramine) 
in plasma cortisol level (20.32 ± 2.26 ng/ml) compared to 
unstressed control (11.05 ± 1.3). This effect was slightly decreased 
at 100 mg dose whereas doses at 200 and 400 mg produced a 
marked reduction to 15.92 ± 2.3 and 16.45 ± 2.3 ng/ml respectively 
that are comparable to the standard group value of 13.88 ± 1.6 
ng/ml. Figure 3  
a)  
 
b) 
 
Figure 3.Effect of methanolic extract of A.calamus rhizome on 
moanoamine oxidase A (a) and B (b) activity in mice brain 
homogenate. Group I (normal control), Group II (Stress control), 
Group III (AC, 100 mg/kg), Group IV (AC, 200 mg/kg), Group V 
(AC, 400 mg/kg), Group VI (Imipiramine) 
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Day 1 Day 14 
Group I (Vehicle control)  
Group II (Stress vehicle)  
Group III (AC, 100mg/kg) 
Group IV (AC, 200 mg/kg)  
Group V (AC, 400 mg/kg) 
Group VI (Imipiramine) 
 
23.5 ± 2.6 
22.4 ± 3.4 
25.4 ± 3.2 
21.8 ± 2.7 
20.6 ± 3.5 
24.2 ± 3.1 
30.5 ± 3.6 
28.9 ± 2.6 
30.6 ± 2.8 
28.4 ± 3.2 
27.4 ± 2.4 
31.6 ± 2.8 
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shows a significant (p<0.001) increase in activities of MAO-A 
(57.48 ± 4.5 U/g protein) and MAO-B (48.47 ± 3.87 U/g) in whole 
brain tissues of mice that is exposed to swim stress compared to 
unstressed control. The treatment with extract caused a marked 
reduction in the elevated level of MAO-A at 200 and 400 mg doses 
whereas MAO-B was inhibited significantly only by higher dose. 
The effect was observed to be insignificant at the lower dose. The 
standard drug (Imipiramine) could block the activities of both the 
MAO significantly. 
The effect of A.calamus extract on whole brain neurotransmitter 
levels in unstressed and stressed mice is presented in Table 2.  
 
 
Table 2.Effect of oral administration of methanolic extract of A.calamus rhizome on brain monoamine neurotransmitters level in FST exposed 
mice. 
 
 
 
 
 
 
 
 
 
 
 
 
# P<0.05,##P<0.001 compared to normal control 
*P<0.05,**P<0.01, ,**P<0.001  compared to stressed control 
 
Swim stress markedly reduced the levels of noradrenaline, 
dopamine, 5-HT and 5-HIAA. The treatment with extract 
significantly increased the noradrenaline level in a U-shaped trend 
dose dependently and the 200 mg dose produced a maximum 
effect while 100 mg extract failed to do so. The decreased level of 
dopamine was only attenuated significantly at the higher dose of 
400 mg whereas the other doses failed to increase the dopamine 
content. The dose dependant effect of extract on 5-HT level was 
similar to that of NA. FST test also indicated a tendency toward an 
increase in 5-HT/HIAA ratio (0.354 ± 0.01) compared to 
unswimmed control (0.290 ±.0.03). Pretreatment of mice with 
extract produced a pronounced effect by decreasing the ratio of 5-
HT/HIAA (0.301 ± 0.03) only at 200 mg dose and was comparable 
to that of standard drug. 
 In a separate experiment, the oral administration of the extract at 
all the three doses for 14 days period did not produce any overt 
behavioral change or motor dysfunction compared to control as 
shown in Figure 4. 
 
 
Figure 4.Effect of methanolic extract of A.calamus rhizome on 
locomotor activity of mice. Group I (normal control), Group II 
(Stress control), Group III (AC, 100 mg/kg), Group IV (AC, 200 
mg/kg), Group V (AC, 400 mg/kg), Group VI (Imipiramine) 
Discussion 
In the present study, we have evaluated the antidepressant activity 
of methanol extract of A.calamus rhizome (MEA) in mice by forced 
swimming test. It is a behavioral test for screening the drugs or the 
plant material for its antidepressant like effect. When subjected to 
unavoidable stress such as FST, the rodents’ display of immobility 
is thought to reflect a state of despair or lowered mood, which 
reflects depressive illness in humans. It is also assumed that the 
animals have given up the hope of escaping from the restricted 
area. It has been reported that the antidepressant drugs have the 
ability to reduce this immobility period in animal model [23-24] . 
The present study also showed that the MEA administered for 14 
days could significantly reduce the immobility time in FST at the 
medium and higher doses used compared to stress control in a U-
shaped dose-dependant fashion and such an activity curve has 
also been reported for several herbal medicines like Apocynum 
venetum, St.Jhon’s wort extract [25-26] albeit the reason for this 
response is obscure. These results suggest that MEA may have an 
anti-depressant effect only in certain dose range. 
There are numerous reports also indicating that swimming stress 
potentially activates HPA axis system leading to the elevation of 
corticosterole release factor (CRF) and corticosterone levels in 
plasma. This increased level of biomarkers is an indicator of stress 
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response mechanism. The role of corticosterone has earlier been 
demonstrated in a study where the administration of corticosterone 
caused an increase in immobility period [27]. Our data also 
demonstrate that swim stress elevated the plasma cortisol level 
and this effect was maximally reduced at 200 mg dose used. It is 
clear from the present study that the possible explanation for the 
antidepressant effect seen following MEA treatment could involve 
preventing the activation of HPA axis and that is similar to the 
earlier reports. 
It has been reported that the stress of FST significantly elevate the 
brain activities of MAO- A and B in mice. Neurotransmitters such 
as serotonin and noradrenaline are preferentially degraded MAO-
A, while dopamine is degraded equally by both the species of 
MAO. Thus, the availability of neurotransmitters level is regulated 
by the MAO enzyme activities and appears to play important role in 
several neurological and psychiatric disorders. The stress of FST 
exposure increases activities of MAO which consequently 
decrease the neurotransmitters level in brains of mice. The present 
study also shows that there is an increase in activities of MAO-A 
and MAO-B swim stresses mice. This trend is in good agreement 
with the earlier published reports [28-29] . The bioactive 
compounds present in the MEA might have caused a marked 
reduction in the elevated level of MAO-A by medium and higher 
doses used whereas MAO-B was inhibited significantly only by 
higher dose. The effect was observed to be insignificant at the 
lower dose. There are substantial reports indicating that MAO is a 
potential target for the treatment of depression and anxiety [30].  
In swim stress experiments, the neurotransmitter levels in the brain 
have been reported as a key factor in mediating the reduction of 
immobility period. The rate of catabolism of neurotransmitters can 
be analysed by measuring the original transmitters and their 
metabolites as a consequence of MAO activities. This ratio is an 
index for the catabolic rate of neurotransmitters. The data 
presented in this study demonstrated that the swim stress 
markedly reduced the levels of neurotransmitters. FST test also 
indicated a tendency toward an increase in 5-HT/HIAA ratio 
compared to unswimmed control which is in concordance with the 
previously published reports[31] . The treatment with extract at the 
medium dose significantly increased the noradrenaline as well as 
level 5-HT level. This may be due to the inhibitory effect of the 
phytoconstituents present in the MEA extract as mentioned earlier 
on MAO activities that prevented the neurotransmitters turnover. 
Psychostimulants such as caffeine or amphetamine and other 
drugs sometimes exert a false positive effect for anti-depression 
activity via increased locomotory activity. This effect can be 
excluded by carrying out an open-field test in parallel with FST as a 
check [32] . The results of the present study did not produce any 
overt behavioral change or motor dysfunction following MEA 
administration. Therefore, the reduction in immobility time as 
observed through the forced swimming test can be attributed to an 
inherent antidepressant-like effect of the extract and not due to 
stimulation of locomotor activity. 
Earlier reports have investigated the attenuating effect of 
A.calamus rhizome oil and leaf extracts [33], and here, we have 
studied the polyphenols-rich methanol extract towards anti-
depressive effects. Various phytochemicals such as polyphenolic 
acids, flavonoids, alkaloids, saponins, xanthones of several 
medicinal plants have been reported as antidepressants through 
the inhibition of MAO activity [34-38]. Recent reports have shown 
that polyphenols such as rutin, trans-resveratral, proanthocyanidin, 
naringenin, rosmarinic acid and caffeic acid have poptential 
antidepressive properties [39-42].  It is likely that the anti-
depressant effect of the A.calamus could be attributed to the 
presence of polyphenols and other active constituents present in 
the extract.  
Conclusion 
Taken together, our results clearly demonstrates that the oral 
administration of methanol extract of rhizome of A.calamus 
possesses an antidepressant-like activity, probably by modulating 
the central neurochemical as well as HPA axis in response to 
stress induced by FST. Therefore, our findings suggest the use of 
A.calamus rhizome as a valuable botanical supplement for treating 
depression related conditions. Further, detailed investigations are 
needed to fully elucidate the mechanism of action at cellular level 
for the bioactive constituents present in the extract. 
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